We have previously identified a sequence in the 3-untranslated region (3-UTR) of erythropoietin (Epo) mRNA which binds a protein(s), erythropoietin mRNA-binding protein (ERBP 
Erythropoietin is a glycosylated protein that plays a central role in erythropoiesis by supporting the proliferation and differentiation of erythroid progenitor cells in the bone marrow (1) . Reduced oxygen tension (hypoxia) is the principle physiological stimulus for Epo 1 production in the fetal liver (2) and in the kidney after birth (3) (4) (5) . The human hepatoblastoma cell lines, HepG2 and Hep3B, have been used extensively to study Epo gene regulation because of their ability to secrete Epo in response to hypoxia and cobalt chloride in a physiological manner (6) .
Comparison of human and mouse Epo gene sequences has provided information regarding highly conserved cis-regulatory elements which exist within the 5ЈUTR, the first intron, and 3Ј-and 5Ј-flanking regions of the Epo gene (7) (8) (9) . Analysis of these conserved sequences has provided abundant information regarding tissue-and stimulus-specific gene expression of Epo (10) . Using reporter gene constructs, a 3Ј enhancer element flanking the Epo gene as well as a 5Ј minimal sequence required for basal promoter activity have each been shown to confer a 4-to 14-fold induction of Epo gene transcription in response to hypoxia in Hep3B cells (11) . Furthermore, these elements appear to act synergistically by causing a 40-to 50-fold induction in transcription in response to hypoxia (11, 12) . This induction in transcription leads to an increase in the Epo mRNA steady-state level throughout the first 8 h after which period the Epo mRNA level decreases (13) . Interestingly, the increase in Epo mRNA level in response to hypoxia cannot be accounted for by a 5-to 10-fold increase in transcription rate in response to hypoxia (14, 15) . Furthermore, while Epo mRNA levels decrease during prolonged hypoxia, the Epo protein level continues to increase for up to 24 h following hypoxic induction (6) . Taken together, these findings suggest that Epo gene expression may be partly regulated at the post-transcriptional level.
Several genes which appear to be regulated by hypoxia are regulated at the post-transcriptional level (10, 16) . Using Northern blot analysis and quantitative polymerase chain reaction (PCR), the half-life of Epo mRNA in normoxia was determined to be 1.5-2 h (13, 14) . In experiments using actinomycin D to block transcription, the half-life of Epo mRNA was extended to 7-8 h in both normoxia and hypoxia (14) . In addition, Epo mRNA half-lives were also prolonged in Hep3B cells treated with cyclohexamide (14) . These observations led Goldberg and co-workers (12, 14) to suggest that Epo mRNA stability may be modulated by a rapidly turning over destabilizing protein.
We have previously reported that a protein(s), erythropoietin mRNA-binding protein, specifically binds to a pyrimidine-rich 120-bp region in the 3ЈUTR of Epo mRNA (17) . We have also demonstrated that in vitro ERBP complex formation was increased using cytoplasmic lysates of various tissues from mice exposed to hypoxia (17) . In this study, we investigate the effect of ERBP complex formation on Epo mRNA stability in normoxia and hypoxia. A mutated Epo gene with a deleted ERBP binding region was generated. In addition, both wild-type and mutant Epo constructs lack hypoxic responsive elements such that changes in mRNA stability in hypoxia would only reflect hypoxic modulation of ERBP complex formation. We are fully aware that actinomycin D prolongs the half-life of Epo mRNA (14) . However, actinomycin D may be employed in this study to determine the effect of ERBP complex formation on Epo mRNA stability, if ERBP complex formation is not affected by actinomycin D. Moreover, this study does not attempt to determine the physiological half-life of either the Epo wild-type or the mutated Epo mRNA, but rather to compare the differences in their mRNA stabilities. The mRNA half-lives, steady-state mRNA levels, and protein levels of Hep3B cells stably transfected with either the exogenous wild-type Epo gene or the mutant Epo gene and exposed to either normoxia or hypoxia were compared. Furthermore, the effect of ERBP complex formation on the mRNA stability of a heterologous gene, chloramphenicol acetyltransferase (CAT), was examined.
EXPERIMENTAL PROCEDURES
Cell Culture-Human hepatoblastoma (Hep3B) cells were obtained from the American Type Culture Collection and grown in Eagle's minimal essential medium (Life Technologies, Inc.) supplemented with 100 units/ml penicillin, 100 units/ml streptomycin, 0.1 mM nonessential amino acids, 0.2 mM glutamine, 1 mM pyruvate, and 10% fetal bovine serum (Cellgro) and were maintained in a humidified 5% CO 2 incubator at 37°C. Cells exposed to hypoxia were grown in a controlled atmosphere chamber supplied with a constant flow of a hydrated 1% O 2 , 5% CO 2 , balanced N 2 gas mixture (18) . All experiments were performed as cells approached 70 -80% confluency. Electromobility Shift Assay-Hep3B cells were grown in the absence or presence of 5 g/ml actinomycin D (Sigma). Cell lysates used in electromobility shift assays were prepared from Hep3B cells which were pelleted, washed, resuspended, and lysed in 25 mM Tris-HCl (pH 7.9) and 0.5 mM EDTA by four freeze-thaw cycles. Following cell lysis, the samples were centrifuged at 10,000 ϫ g at 4°C for 10 min, and the supernatant was removed and stored at Ϫ70°C. The protein concentrations of the cell lysates were determined by a Bradford protein assay as described by the manufacturer (Bio-Rad).
Constructs and Establishment of Transfected Cell Lines-Human
Full-length sense-strand radiolabeled RNA run-off transcripts were generated by incubating 5 M were grown in either normoxia or hypoxia (6 h or 12 h) prior to the addition of 5 g/ml actinomycin D (Sigma) (14) . WT , and CAT-Epo M were determined by co-amplification with glyceraldehyde-3Ј-phosphate dehydrogenase (GAPDH) mRNA. Primer p475 (5Ј-GACAGAGCCATGCTGGGAAGAC-3Ј), located in the 3ЈUTR of the Epo gene, and primer p471 (5Ј-CGCCAGTGTGATGGATATCTGC-3Ј), located in the vector pcDNA3 sequence, were used to amplify mRNA transcribed from the exogenous Epo gene in all experiments. Primer p427 (5Ј-GAAGGTGAAGGTCGGAGTCAACG-3Ј), located in exon 1, and primer 428 (5Ј-TGCCATGGGTGGAATCATATTGG-3Ј), located in exon 3, were used to amplify GAPDH mRNA. Primer p472 (5Ј-TCA-CATTCTTGCCCGCCTGAT-3Ј) and primer p473 (5Ј-AGGGATTGGCT-GAGACGAAAAACAT-3Ј) were used to amplify CAT mRNA from Hep3B cells stably transfected with pcDNA3-CAT vector. Single-step RT-PCR was carried out using rTth DNA polymerase I (19) . RT-PCR conditions were 10 -100 ng of total RNA, 1 ϫ EZ buffer (50 mM Bicine, 125 mM KOAc, 8% glycerol, pH 8.2) (Perkin-Elmer), 3.5 mM Mn(OAc) 2 , 200 M concentration of each deoxyribonucleotide triphosphate, 400 nM p471 and p475, 100 nM p427 and p428, and 5 units of rTth DNA polymerase I (Perkin-Elmer) in a 50-l reaction. The cycling parameters were 95°C 1 min, 65°C 30 min, followed by 35-42 cycles of 95°C 30 s, 60°C 30 s, 72°C 40 s. One-fifth of each reaction was analyzed on 3% NuSieve (FMC) plus 0.5% agarose gel. The amount of PCR products from Epo mRNA or CAT-Epo mRNA was normalized to PCR products from GAPDH mRNA for each time point by densitometry using NIH Image.
Steady-state mRNA levels of exogenous Epo WT and Epo M in normoxia were determined by comparing the lowest detectable levels using serially diluted total RNA. Total mRNA from Hep3B cells transfected with pcDNA3-Epo WT or pcDNA3-Epo M was serially diluted 1:1 from 5 g/l to 1.25 ng/l. Two aliquots of 10 l of each dilution were coamplified with primers p471 and p475 for exogenous Epo WT or Epo M mRNA and primers p427 and p428 for GAPDH mRNA for 36 cycles. The end point for GAPDH mRNA was used to monitor the equivalency of the total RNA between Epo WT and Epo M . Erythropoietin Radioimmunoassay-Untransfected Hep3B cells or those transfected with Epo WT or Epo M were grown to 70 -80% confluency and then maintained in normoxia or exposed to hypoxia. After 20 h, the supernatant was removed and the amount of erythropoietin was determined by an erythropoietin radioimmunoassay (20, 21) . Recombinant Epo was used in a range of 3.125-400 milliunits/ml to prepare a standard curve (21) . The Epo levels in culture medium are expressed in milliunits/ml and were normalized to either total cellular protein or cell number.
Chloramphenicol Acetyltransferase Assay-CAT activity in Hep3B cells stably transfected with pCAT-Epo WT , pCAT-Epo M , or pcDNA3-CAT and grown in normoxia were determined using a non-radioactive FLASH ® CAT-Deoxy assay (Stratagene) according to the manufacturer's instructions. Fifty g of cytoplasmic lysates, prepared as described under "electromobility shift assay," from each cell line was used in each reaction, and the acetylation reaction was visualized using thin-layer chromatography. The percentage of acetylated product was quantified by the relative absorption at 505 nm or by densitometry using NIH image. CAT activity is shown as the mean Ϯ S.D. of the percentage of acetylation of five experiments.
Statistical Analysis-Individual half-lives for each experiment were determined by linear regression lines of the first four time points drawn by the Microsoft Excel program. mRNA half-lives are presented as the mean Ϯ S.D. of all of the experiments (n). Student's unpaired t test was employed to assess the difference between mRNA half-lives of two groups. The mRNA decay rates are illustrated graphically, and each time point is represented as the mean Ϯ S.D. of relative Epo or CATEpo mRNA levels of all of the experiments.
RESULTS
Deletion of the ERBP Binding Site-We have previously reported that a 120-nucleotide region in the 3ЈUTR of Epo mRNA is necessary for ERBP binding (17) . To investigate the effect of ERBP binding on the stability of Epo mRNA, the ERBP binding site was deleted using PCR mutagenesis. In the 3ЈUTR region of Epo M , a 104-bp region between the stop codon and NcoI sites was replaced with a 17-bp sequence, which resulted in an 87-bp deletion and was confirmed by sequencing. Run-off transcripts were prepared from pcDNA3-Epo M or pcDNA3-Epo WT , and electromobility shift assay was performed using cytoplasmic lysates from untransfected Hep3B cells cultured in normoxia. Fig. 1 demonstrates that while ERBP is able to form a complex with radiolabeled Epo WT run-off RNA, Epo M run-off RNA, which lacks the binding sequence for ERBP, is unable to form a complex with ERBP. The specificity of ERBP binding has been demonstrated previously by competition experiments (17) .
Exogenous Epo mRNA Stability in Normoxia-To determine the effect of ERBP complex formation on the stability of Epo mRNA, Hep3B cells were transfected with pcDNA3-Epo WT or pcDNA3-Epo M and treated with actinomycin D to block transcription. The Epo WT cDNA and Epo M cDNA were cloned into the multiple cloning sites, downstream of a constitutive promoter of cytomegalovirus and upstream of the polyadenylation signal and termination sequence of the bovine growth hormone gene of a mammalian expression vector pcDNA3.
The possible effect of actinomycin D on the level of ERBP was first examined. Cytoplasmic lysates were prepared from Hep3B cells after various periods of time following the addition of actinomycin D, incubated with radiolabeled Epo WT run-off RNA, and ERBP complex formation was examined by electromobility shift assay. The level of ERBP binding was unchanged at 8 h following addition of actinomycin D but reduced 20% after 14 h and an additional 30% 24 h following actinomycin D treatment when compared with untreated cells (Fig. 2) . Therefore, it appears that the formation of the ERBP complex remained unchanged following 8 h of actinomycin D treatment and decreased slightly at 14 h following treatment.
To distinguish exogenous Epo mRNA from endogenous Epo mRNA, one of the primers for the mRNA decay experiments, p471, was designed to be specific for a sequence located downstream of the Epo gene and upstream of the polyadenylation signal site, in the vector pcDNA3 (Fig. 3A) . Fig. 3B 
WT run-off RNA was detected by electromobility shift assay. Lane 1, Epo WT run-off RNA was incubated in the absence of cytoplasmic cell lysates from Hep3B cells as a negative control.
FIG. 3. Specific amplification of exogenous Epo mRNA.
A, the locations of primers for distinguishing exogenous Epo mRNA from endogenous Epo mRNA. B, RT-PCR was performed as described under "Experimental Procedures." Lanes 1 and 3 were negative controls of amplifications with primers p221 and p220 and primers p221 and p471, respectively. Lanes 2 and 4, total RNA from Hep3B cells were amplified with primers p221 and p220 and primers p221 and p471, respectively. Lanes 5 and 6, total RNA from Hep3B cells transfected with pcDNA3-Epo M and pcDNA3-Epo WT was amplified with primers p221 and p471, respectively. Primer p471 was designed to specifically amplify the exogenous Epo mRNA; therefore, no PCR products were detected in lane 4. The marker lane is a 100-bp ladder (Life Technologies, Inc.).
strates the specificity of primer p471 for exogenous mRNA of Epo WT and Epo M (lanes 5 and 6). Single-step RT-PCR using rTth DNA polymerase was used to carry out reverse transcription at an elevated temperature and to prevent contamination. The sensitivity of RT-PCR with primer pair p471 and p475 was determined to be 100 molecules using Epo WT run-off transcripts. The absence of DNA contamination in total RNA preparations was confirmed by amplification without the reverse transcription step.
Total RNA was prepared from Hep3B cells transfected with pcDNA3-Epo WT or pcDNA3-Epo M at various time points following addition of actinomycin D. Hep3B cells stably transfected with the pcDNA3-Epo WT or pcDNA3-Epo M construct (Fig. 4A ) were pooled to avoid bias in the level of variable gene expression. The amount of total RNA used in each RT-PCR reaction and the cycling number were determined empirically to ensure that the amplification of either Epo mRNA or GAPDH mRNA did not reach plateau. The level of Epo mRNA at each time point was quantified by normalizing it with co-amplified GAPDH mRNA. Fig. 4B illustrates the mRNA decay rates for exogenous Epo WT and Epo M in normoxia. The mRNA half-life of Epo WT , 7.1 Ϯ 1.4 h (n ϭ 6), was significantly (p ϭ 0.00001) different from the mRNA half-life of Epo M , 2.6 Ϯ 0.5 h (n ϭ 6). These results suggest that ERBP binding prolongs the stability of Epo mRNA, and the shorter half-life of Epo M mRNA in normoxia is likely due to the absence of ERBP complex formation.
Steady-state exogenous Epo mRNA levels in pcDNA3-Epo WT or pcDNA3-Epo M transfected Hep3B cells were compared by RT-PCR using serially diluted total RNA. RT-PCR was performed using serially diluted total RNA to determine the lowest quantity of total RNA for which Epo WT shown in both Fig. 4B and Fig. 6 . The half-lives of Epo WT mRNA and Epo M mRNA were 9.8 Ϯ 2.0 h (n ϭ 6) and 3.0 Ϯ 1.1 h (n ϭ 6), respectively, and the difference was highly statistically significant (p ϭ 0.00002). The Epo WT mRNA half-life in hypoxia increased 2.7 h from the Epo WT mRNA half-life in normoxia (p ϭ 0.021) (Fig. 4B) . Furthermore, there was no significant change in the Epo M mRNA half-life in hypoxia compared with the Epo M mRNA half-life in normoxia (Fig. 4B) . Interestingly, the Epo WT mRNA decay rate appears to decrease between 6 h and 10 h following addition of actinomycin D, corresponding to between 12 h and 16 h of hypoxic exposure. It is likely that following 12 h of hypoxic exposure, in vivo ERBP complex formation might be increased. To investigate this possibility, Hep3B cells stably transfected with pcDNA3-Epo WT or pcDNA3-Epo M were grown in hypoxia for 12 h prior to the addition of actinomycin D, after which the cells were returned to hypoxia and total RNA was extracted at various time points. The mRNA decay rates for exogenous Epo WT and Epo M in hypoxia after 6-or 12-h hypoxic treatment are compared in Fig. 6 . The half-life of Epo WT mRNA increased from 9.8 Ϯ 2.0 h (n ϭ 6) to 14.6 Ϯ 3.9 h (n ϭ 3) (p ϭ 0.039) with an additional 6 h of hypoxic pre-treatment. In contrast, Epo M mRNA half-life remained nearly the same with 6 or 12 h of hypoxic pre-treatment.
Epo Expression Levels-Epo levels in untransfected Hep3B cells and Hep3B cells stably transfected with either pcDNA3-Epo WT or pcDNA3-Epo M and cultured in normoxia or hypoxia were determined using Epo radioimmunoassay (Table  I) . As expected, Epo produced by Hep3B cells was undetectable under normoxia and increased ϳ60-fold under hypoxia. In hypoxia, Epo expressed from the endogenous Epo gene in Hep3B cells also contributed to the observed Epo levels in Hep3B cells transfected with pcDNA3-Epo WT or pcDNA3-Epo M . The Epo level expressed from the endogenous Epo gene accounts for the difference in the Epo levels between Hep3B cells transfected with pcDNA3-Epo M and cultured in normoxia and hypoxia. Therefore, the Epo level expressed from the exogenous Epo M gene was identical under normoxia and hypoxia. In contrast, after subtracting the Epo level contributed by the endogenous Epo gene under hypoxia, the Epo level expressed by the exogenous Epo WT gene increased 1.7-fold compared with the Epo level expressed by the exogenous Epo WT gene in normoxia. The Epo level expressed by the exogenous Epo WT gene was ϳ5-fold higher than that expressed by the exogenous Epo M gene in normoxia. Under hypoxia, the Epo level expressed by the exogenous Epo WT gene was 6-fold higher than that expressed by the exogenous Epo M gene. These data clearly indicate that the effect of ERBP complex formation on the stability of Epo mRNA is also apparent at the protein level.
Epo 3ЈUTR Confers Stability to Chimeric CAT mRNA-To further investigate the possibility that ERBP complex formation confers stability to Epo WT mRNA, we inserted the 3ЈUTR of either Epo WT or Epo M next to a heterologous CAT sequence (Fig. 7A) . The half-life of pCAT-Epo WT was 7.3 Ϯ 1.3 h (n ϭ 3) compared with 3.7 Ϯ 1.7 h (n ϭ 3) for pCAT-Epo M (p ϭ 0.04). The mRNA half-life of pcDNA3-CAT was 3.4 Ϯ 0.9 h (n ϭ 3) which was significantly different from pCAT-Epo WT (p ϭ 0.03) but not from pCAT-Epo M (Fig. 7B) . Fig. 7C illustrates a 3-fold increase in CAT activity produced by pCAT-Epo WT compared with that produced by pCAT-Epo M and pcDNA3-CAT (n ϭ 5). These results suggest that the ERBP complex formation not only acts to stabilize Epo mRNA but also chimeric CAT-Epo WT 3ЈUTR mRNA.
DISCUSSION
The rate at which mRNA decays is a precise and complex process that can determine the level of gene expression. In eukaryotic cells, the process of mRNA degradation is primarily governed by specific cis-acting sequences, trans-acting factors, poly(A) shortening, endonucleolytic cleavage, and translation (22) . In response to environmental stimuli, mRNA decay rates can fluctuate and affect the expression of specific genes, thereby providing the cell with the flexibility to adapt to a changing environment.
Epo gene regulation has been studied extensively and compared with other hypoxically regulated genes such as vascular endothelial growth factor (VEGF) and tyrosine hydroxylase (TH) (10, 23) . Several studies have provided evidence that the expression of VEGF, TH, and Epo are regulated at transcriptional or post-transcriptional levels upon exposure to hypoxia (10, 24 -26) . The hypoxic induction of these three genes appears to require the activation of hypoxic inducible factor 1 suggesting that they may all share a common oxygen sensing pathway (10) . In addition, the transcription rates of Epo, VEGF, and TH peak or plateau following hypoxic induction, while steady-state mRNA levels increase or remain elevated throughout the duration of hypoxic exposure (14, 15, 25, 27) . There is also evidence that hypoxic induction plays a role in the post-transcriptional regulation of TH and VEGF gene expression by increasing the stability of each mRNA in hypoxia (25) (26) (27) . Similar to ERBP, proteins have been identified which bind to pyrimidine-rich regions in the 3ЈUTR of both TH mRNA and VEGF mRNA (26, 28, 29) . Prior to our study, only the effect of FIG. 6 . mRNA decay for exogenous Epo in hypoxia with 6-and 12-h hypoxic treatment. To demonstrate the difference in Epo mRNA decay rates with varying periods of hypoxic pre-treatment prior to the addition of actinomycin D, the mRNA decay for Epo WT and Epo M with 6-h hypoxic pre-treatment in Fig. 4B are included in this figure. Ⅺ and f, exogenous Epo WT mRNA decay under hypoxia with 6-and 12-h hypoxic pre-treatment, respectively. E and q, Epo M mRNA decay under hypoxia with 6-and 12-h hypoxic pre-treatment, respectively. Each point represents the average of two or three amplifications using total RNA prepared from two different actinomycin D chase experiments. Actinomycin D chase and quantification of exogenous Epo mRNA levels were described under "Experimental Procedures." (26) . It has also been suggested that Epo gene expression may be regulated at the posttranscriptional level; however, no direct evidence has been reported to support this hypothesis. In our study, constructs containing only the Epo cDNA sequence were used; therefore, the observed differences in Epo WT mRNA and Epo M mRNA stability in both normoxia and hypoxia were attributed to the hypoxic modulation of ERBP complex formation.
Actinomycin D has been reported to extend Epo mRNA halflife through the modulation of a putative protein(s) with a rapid turning over rate (12, 14) . WT mRNA half-life in normoxia was 7 h which is consistent with previous findings of the half-life for endogenous Epo mRNA in actinomycin D-treated Hep3B cells after hypoxic pre-treatment (14) . The shorter half-life of Epo M mRNA, 2.6 h, implies that ERBP complex formation acts to stabilize Epo mRNA. Moreover, this hypothesis is further supported by results of increased CAT activity and prolonged CAT mRNA stability under normoxia in Hep3B cells transfected with pCAT-Epo WT compared with those transfected with either pCAT-Epo M or pcDNA3-CAT. Although genes of interest with various deleted sequences in the 3ЈUTR have been used extensively to identify the specific mRNA control sites and to elucidate the mechanisms through which they mediate mRNA stability, such data must be interpreted cautiously. We cannot exclude the possibility that the 87-bp deletion may have contained a "stabilizing" cis-element. Moreover, mRNA-binding proteins may bind to either specific mRNA sequences or intrinsic stem-loop(s) structures. It is interesting that when we examined a computer-predicted secondary structure of Epo mRNA, this pyrimidine-rich ERBP binding region is part of several stems pairing with regions in 5ЈUTR, coding sequence, and further downstream in the 3ЈUTR. Specific point mutations to disrupt the pairing in different stem regions will help to delineate whether the secondary structure of Epo mRNA plays a crucial role in ERBP complex formation. A 188-bp region downstream and adjacent to the ERBP binding site has been identified to contain a destabilizing cis-element. Deletion of this region prolonged Epo mRNA half-life to 15 h compared with the endogenous Epo mRNA half-life, 2 h (30). Part of this region forms a stem with the ERBP binding site, and we speculate that ERBP complex formation may play a role in protecting Epo mRNA as the substrate of endonucleolytic cleavage in this region.
The half-lives of exogenous Epo M mRNAs were nearly identical, i.e. 2.5-3 h, when cultured in normoxia and exposed to either 6-or 12-h hypoxia. However, exogenous Epo WT mRNA half-life was increased 38% and an additional 49% over normoxic levels in cells exposed to 6-and 12-h hypoxia, respectively. Rondon et al. (17) have previously reported that while ERBP appears to be hypoxically up-regulated in various mouse tissues, there did not appear to be a difference in ERBP complex formation from cytoplasmic lysates derived from Hep3B cells cultured in either normoxia or hypoxia. However, using modified binding conditions, ERBP complex formation was increased using cytoplasmic lysates from Hep3B cells exposed to FIG. 7 . mRNA decay of CAT-Epo 3UTR hybrids in normoxia. A, constructs of CAT-Epo 3ЈUTR hybrids and pcDNA3-CAT. B, mRNA decay of CAT-Epo WT 3ЈUTR, CAT-Epo M 3ЈUTR, and CAT. Each point represents the average of two amplifications of total RNA prepared from two different actinomycin D chase experiments. f, Ⅺ, and E, mRNA decay of CAT-Epo WT , CAT-Epo M hybrids, and CAT under normoxia, respectively. Actinomycin D chase and quantification of CATEpo3ЈUTR hybrid mRNA levels were determined as described under "Experimental Procedures." C, CAT activity from Hep3B cells transfected with pCAT-Epo WT , pCAT-Epo M , and pcDNA3-CAT. CAT activity was determined with non-radioactive FLASH ® CAT-Deoxy assay using 1-deoxychloramphenicol as substrate.
hypoxia. 2 Therefore, the prolonged half-life of Epo WT mRNA is most likely due to increased ERBP complex formation under hypoxia. In contrast, the half-life of Epo M mRNA, lacking the ERBP binding site, remained unchanged in hypoxia. Furthermore, the hypoxic modulation of Epo mRNA was supported by comparing Epo levels expressed by endogenous Epo, exogenous Epo M , or exogenous Epo WT measured in normoxia or after 20-h hypoxia. In hypoxia, Epo produced by Hep3B cells transfected with pcDNA3-Epo M was twice the amount produced by endogenous Epo in untransfected Hep3B cells, and it was also twice that produced by pcDNA3-Epo M in normoxia. This suggests that the absence of ERBP binding formation is likely responsible for the non-hypoxic responsive expression of the exogenous Epo M gene. However, there was a 1.7-fold difference between the Epo level expressed by the exogenous Epo WT gene under hypoxia and normoxia, likely due to the ϳ2-fold increase in Epo WT mRNA half-life observed in prolonged hypoxia. We conclude that the increase in Epo mRNA stability in hypoxia may account for the discrepancy between decreasing Epo mRNA steady-state levels and increasing Epo expression observed in prolonged hypoxia. We have demonstrated that Epo mRNA stability is increased by the binding of ERBP to the 3ЈUTR of Epo mRNA. Moreover, the increase in Epo mRNA stability in hypoxia is likely modulated by an increase in ERBP complex formation in hypoxia. Our data have provided the first evidence that Epo mRNA stability is regulated at the posttranscriptional level and shed some light on the mechanism of Epo gene regulation.
